All lobbying filings
Apco Worldwide LLC
Apco Worldwide LLC filed a Q3 report for Hikma Pharmaceuticals USA Inc. on October 19, 2026, reporting $70,000 in lobbying income.
Lobbying for Hikma Pharmaceuticals USA Inc. · Pharmaceutical manufacturer
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
2
-
ALLISON PARKER-LAGOOPreviously held: Assistant to the Chief of Staff, Sen. Hagan
-
DAN SCANDLINGPreviously held: Chief of Staff & Press Secretary, Rep. Bateman
Government bodies contacted
4
Lobbying activity
2
Trade policies impacting domestic generic pharmaceutical manufacturing
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues